Treatment Strategies in Myelodysplastic Syndromes

By Atallah Ehab   Garcia-Manero Guillermo  

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 208-216

Informa Healthcare

Access to resources Recommend Favorite

Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D.   Rolović Z.   Ćemerikić V.   Bošković D.   Ćolović M.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndromes: Clinical and biological significance

By Marisavljević Dragomir   Čemerikić Vesna   Rolović Zoran   Bošković Darinka   Čolović Milica  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 169-175

Humana Press, Inc

Access to resources Recommend Favorite

Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes

By Marisavljević D.   Rolović Z.   Šefer D.   Basara N.   Ilić D.   Bošković D.   Čolović M.  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 249-259

Humana Press, Inc

Access to resources Recommend Favorite

Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes

By Tehranchi R.  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 37-49

Humana Press, Inc

Access to resources Recommend Favorite